ProQuest and Scopus Announce Unique Partnership to Enhance the Research Workflow
Users' research becomes even more effective
Ann Arbor, Mich. – June 4, 2007 – ProQuest and Scopus are pleased to announce a unique reciprocal searching and linking partnership that will expand the research capabilities of mutual customers of CSA Illumina™ and Scopus®. This integration will enable users of CSA Illumina to find 4,500 Scopus titles in natural sciences, business, and economics directly integrated in their search results. In turn, Scopus users will be able to view records from selected leading ProQuest databases in social sciences from the CSA Illumina platform.
CSA Illumina, from ProQuest, is a robust digital platform for bibliographic and full-text searching of more than 100 databases covering social sciences. Scopus is the largest abstract and citation database of research literature and quality web sources with smart tools to track, analyze and visualize research, covering over 15,000 titles from more than 4,000 international publishers.
Mutual users will be able to cross-search the comprehensive and superior coverage of both well-established products in either single interface without any extra effort. Additional search results will be seamlessly integrated in the results set with a direct link to the original record on the native product and to full text if available.
"ProQuest selectively considers partnerships that improve discovery, that can open new, more direct paths to high quality research. This is a great example of that strategy in action," said Matt Dunie, president of ProQuest. "Now on both platforms, a single search will now provide researchers with improved depth and breadth of content that supports research in STM, business, and the social sciences."
Key bibliographic records from Scopus in natural sciences, business, and economics will be made available on the CSA Illumina platform. In turn, high quality titles in social sciences on the CSA Illumina platform, such as CSA Sociological Abstracts and Applied Social Sciences Index and Abstracts, will be made available on Scopus.
"This partnership makes literature research even more effective using Scopus and CSA Illumina," said Jaco Zijlstra, Scopus Director. "Wherever users start their research, they can be sure to find the most comprehensive coverage of science, technology, medicine, and social sciences literature available, while still taking advantage of all features that Scopus and CSA Illumina offer."
This reciprocal linking capability is available at no additional charge to customers who have both licensed the selected content from both CSA Illumina and Scopus, offering these customers even more return on their investment. Mutual customers will receive a notification when the linking agreement is activated at their institution.
# # #
ProQuest combines the strengths of two leading and historic information technology firms: ProQuest Information and Learning and CSA. The company provides seamless access to and navigation of more than 125 billion digital pages of the world’s scholarship, delivering it to the desktop and into the workflow of serious researchers in multiple fields, from arts, literature, and social science to science, technology, and medicine. ProQuest is part of Cambridge Information Group.
ProQuest’s vast content pools are available to researchers through libraries of all types and include the world’s largest digital newspaper archive, periodical databases comprising the output of more than 9,000 titles and spanning more than 500 years, the preeminent dissertation collection, and various other scholarly collections. Users access the information through the ProQuest® and CSA Illumina Web-based online information systems, Chadwyck-Healey™ electronic and microform resources, UMI® microform and print reference products, eLibrary® and SIRS® educational resources, Ulrich's Serials Analysis System™, COS Scholar Universe, and Serials Solutions resource management tools. Through the expertise of business units Serials Solutions and COS, ProQuest provides technological tools that allow researchers and libraries to better manage and use their information resources. For more information, visit www.proquest.com and www.csa.com.
Covering the world’s research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. Scopus is designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 peer reviewed journals from 4,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates web & patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool.
For more information about Scopus please visit www.info.scopus.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Fusion Public Relations
Tel: +1 202 898 2000, ext. 117
Tel: +1 734 761 4700, ext. 2540